Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australian Court Orders Biota Dispute With GSK To Mediation (Australia)

This article was originally published in PharmAsia News

Executive Summary

An Australian judge ordered Biota Holdings to mediation in its dispute with GlaxoSmithKline over the marketing of the flu drug Relenza (zanamivir). Biota accused GSK in a court suit of not properly promoting the drug Biota developed and GSK licensed. The judge ordered mediation to be completed by May 16, 2008. Biota sued GSK in Australia for as much as $606 million, U.S., noting the drug's sales were overshadowed by Roche Holding's Tamiflu. (Click here for more
Advertisement

Related Content

Aussie Biotech Biota Closer To Resolution With GSK On Relenza Suit
Advertisement
UsernamePublicRestriction

Register

SC065880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel